In a mouse model of mutant K-rasG12D-induced lung cancer, suppressing the Nrf2 pathway with the chemical inhibitor Brusatol enhanced the antitumor efficacy of cisplatin [24]. This evidence concerns the gene NFE2L2 and lung carcinoma.